TISLELIZUMAB-JSGR

TISLELIZUMAB-JSGR was reported 224 times

These side effects are most commonly reported by patients taking TISLELIZUMAB-JSGR:

# Side effect Count
0 DISEASE PROGRESSION 80
1 OFF LABEL USE 26
2 MALIGNANT NEOPLASM PROGRESSION 25
3 ANAEMIA 21
4 THROMBOCYTOPENIA 21
5 LYMPHADENOPATHY 19
6 PNEUMONIA 12
7 DECREASED APPETITE 10
8 RICHTER^S SYNDROME 10
9 DEATH 9
10 PYREXIA 9
11 HYPONATRAEMIA 8
12 NEUTROPHIL COUNT DECREASED 7
13 C-REACTIVE PROTEIN INCREASED 6
14 INFUSION RELATED REACTION 6
15 NAUSEA 6
16 RENAL IMPAIRMENT 6
17 FEBRILE NEUTROPENIA 5
18 MYELOSUPPRESSION 5
19 NEUROPATHY PERIPHERAL 5
20 PRODUCT USE IN UNAPPROVED INDICATION 5
21 HYPOTHYROIDISM 4
22 INTERSTITIAL LUNG DISEASE 4
23 MALAISE 4
24 METASTASES TO LIVER 4
25 STOMATITIS 4
26 TUMOUR PERFORATION 4
27 ALANINE AMINOTRANSFERASE INCREASED 3
28 ANAPHYLACTIC SHOCK 3
29 ASPARTATE AMINOTRANSFERASE INCREASED 3
30 DIARRHOEA 3
31 DRUG INEFFECTIVE 3
32 ENTEROCOLITIS 3
33 FALL 3
34 HEPATIC FUNCTION ABNORMAL 3
35 INFECTION 3
36 METASTASES TO LUNG 3
37 VOMITING 3
38 WHITE BLOOD CELL COUNT DECREASED 3
39 ACUTE KIDNEY INJURY 2
40 ADRENAL INSUFFICIENCY 2
41 ALOPECIA 2
42 ASTHENIA 2
43 BRADYCARDIA 2
44 CARDIAC ARREST 2
45 CARDIAC FAILURE 2
46 CHILLS 2
47 DIABETIC NEUROPATHY 2
48 FEMORAL NECK FRACTURE 2
49 HEADACHE 2
50 HEPATITIS 2
51 HEPATOTOXICITY 2
52 HYPERGLYCAEMIA 2
53 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2
54 LEUKOPENIA 2
55 METASTASES TO CENTRAL NERVOUS SYSTEM 2
56 METASTASES TO LYMPH NODES 2
57 NEUTROPENIA 2
58 NEUTROPENIC SEPSIS 2
59 PERFORMANCE STATUS DECREASED 2
60 PERICARDIAL EFFUSION 2
61 PLATELET COUNT DECREASED 2
62 PNEUMONIA ASPIRATION 2
63 POLYNEUROPATHY 2
64 RASH 2
65 RESPIRATORY FAILURE 2
66 STEVENS-JOHNSON SYNDROME 2
67 THERAPEUTIC RESPONSE DECREASED 2
68 ADRENAL DISORDER 1
69 ALTERED STATE OF CONSCIOUSNESS 1
70 ANAPHYLACTIC REACTION 1
71 APPENDICITIS PERFORATED 1
72 ASCITES 1
73 ATRIAL TACHYCARDIA 1
74 CARDIAC DISORDER 1
75 CARDIAC TAMPONADE 1
76 CAROTID ARTERY STENOSIS 1
77 CEREBRAL INFARCTION 1
78 CEREBROVASCULAR ACCIDENT 1
79 CHEST PAIN 1
80 CHOLANGITIS 1
81 CHOLESTASIS 1
82 CONDITION AGGRAVATED 1
83 COVID-19 1
84 CYSTITIS 1
85 CYTOKINE RELEASE SYNDROME 1
86 CYTOMEGALOVIRUS ENTERITIS 1
87 CYTOPENIA 1
88 DEAFNESS 1
89 DEHYDRATION 1
90 DERMATITIS 1
91 DEVICE RELATED INFECTION 1
92 DIZZINESS 1
93 DRUG HYPERSENSITIVITY 1
94 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
95 DUODENAL ULCER HAEMORRHAGE 1
96 DYSPHAGIA 1
97 DYSPNOEA 1
98 ENZYME LEVEL INCREASED 1
99 FATIGUE 1
100 FEEDING DISORDER 1
101 GASTROINTESTINAL STENOSIS 1
102 GENERAL PHYSICAL HEALTH DETERIORATION 1
103 GYNAECOMASTIA 1
104 HAEMATOCHEZIA 1
105 HEPATIC FAILURE 1
106 HEPATITIS ACUTE 1
107 HIP FRACTURE 1
108 HYPERAMMONAEMIA 1
109 HYPERSENSITIVITY 1
110 HYPERTRIGLYCERIDAEMIA 1
111 HYPERVOLAEMIA 1
112 HYPOAESTHESIA 1
113 HYPOKALAEMIA 1
114 ILEUS PARALYTIC 1
115 IMMUNE-MEDIATED ENCEPHALITIS 1
116 IMMUNE-MEDIATED ENTEROCOLITIS 1
117 IMMUNE-MEDIATED THYROIDITIS 1
118 IMMUNOSUPPRESSION 1
119 INFLAMMATION 1
120 LICHEN PLANUS 1
121 LIVER FUNCTION TEST ABNORMAL 1
122 LOSS OF CONSCIOUSNESS 1
123 LUNG DISORDER 1
124 LUNG NEOPLASM 1
125 LYMPHOMA 1
126 MEDIASTINITIS 1
127 MEDICAL DEVICE SITE INFECTION 1
128 MELAENA 1
129 MENTAL DISORDER 1
130 METASTASES TO BONE 1
131 METASTASES TO CHEST WALL 1
132 MOUTH BREATHING 1
133 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 1
134 NEOPLASM PROGRESSION 1
135 OESOPHAGEAL CARCINOMA 1
136 OESOPHAGEAL PERFORATION 1
137 OESOPHAGEAL WALL HYPERTROPHY 1
138 PAIN 1
139 PANCREATITIS 1
140 PERFORATION 1
141 PERIPHERAL SENSORIMOTOR NEUROPATHY 1
142 PNEUMOCYSTIS JIROVECII PNEUMONIA 1
143 PORTAL VENOUS GAS 1
144 PROCALCITONIN INCREASED 1
145 PRURITUS 1
146 PULMONARY EMBOLISM 1
147 PULMONARY SEPSIS 1
148 PULMONARY TOXICITY 1
149 PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY 1
150 RASH PRURITIC 1
151 RASH VESICULAR 1
152 SEIZURE 1
153 SEPSIS 1
154 SHOCK 1
155 SKIN DISORDER 1
156 SURGERY 1
157 SYNCOPE 1
158 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
159 TOXIC ENCEPHALOPATHY 1
160 TOXIC EPIDERMAL NECROLYSIS 1
161 TRACHEAL FISTULA 1
162 TREATMENT FAILURE 1
163 TUMOUR RUPTURE 1
164 TYPE IV HYPERSENSITIVITY REACTION 1
165 UNDERDOSE 1
166 VASCULITIS 1
167 VASCULITIS GASTROINTESTINAL 1
168 WEIGHT DECREASED 1
169 WITHDRAWAL SYNDROME 1